Pink Ventures brings Italian medical aesthetics leader Promoitalia to the Philippines
Pink Ventures officially introduced Italian medical aesthetics leader Promoitalia Medical Aesthetics to the Philippine market through an exclusive launch event that gathered leading dermatologists, aesthetic physicians and clinic owners at Shangri-La The Fort in Bonifacio Global City.
The launch marked Promoitalia’s official Philippine debut and underscored Pink Ventures’ commitment to bringing globally recognized, science-driven innovations to the country’s growing medical aesthetics industry. More than a product launch, the event served as a platform for physician education, highlighting the importance of evidence-based practice and continuous learning in delivering safe and effective aesthetic treatments.
Headlining the scientific program was Dr. Pasquale Ruggiero, Promoitalia’s Italian Key Opinion Leader, who shared the latest developments in regenerative and injectable aesthetic medicine. His presentations covered skin biostimulation, skin quality optimization and physician-led intimate care, reinforcing Promoitalia’s philosophy that clinical excellence begins with science, education and responsible practice.
Founded in Italy, Promoitalia has built an international reputation for combining scientific research, advanced technology and medical innovation to develop aesthetic solutions that promote skin health while delivering natural-looking results. Driven by a commitment to excellence and continuous research, the company has become a trusted name in modern aesthetic medicine.
“At Pink Ventures, we believe Filipino physicians deserve access to the same world-class innovations that are transforming aesthetic medicine around the world,” said Mary Grace Juliano, CEO of Pink Ventures. “Our partnership with Promoitalia is about more than introducing exceptional products. It’s about bringing science, education and internationally recognized clinical expertise closer to our local medical community. We are proud to help shape the future of regenerative aesthetic medicine in the Philippines.”
The partnership reflects Pink Ventures’ vision of equipping Filipino physicians with internationally developed treatment platforms while fostering a culture of continuous learning and responsible aesthetic practice. Throughout the launch, guests explored Promoitalia’s portfolio of regenerative aesthetic solutions and engaged with international experts and product specialists in discussions on emerging trends, clinical protocols and best practices.
Among the innovations introduced was the Skinfill Series, Promoitalia’s portfolio of regenerative aesthetic solutions designed to address a wide range of patient needs. The collection includes Skinfill Blue, a bio-restructuring platform that supports overall skin quality; Skinfill Bianco, an injectable treatment that combines pigment management with complexion harmonization; Skinfill Endurance, a next-generation skin booster developed to promote skin longevity and address chronic microinflammation associated with aging; and Skinfill Bacio, a lip-quality treatment that enhances hydration, softness and natural definition without focusing solely on volume enhancement.
The launch also showcased Promoitalia’s Pink Intimate Series, a physician-directed platform for intimate wellness that offers professional treatment protocols focused on hydration, tissue quality and overall intimate rejuvenation.
A highlight of the event was the announcement of an exclusive physician training workshop, allowing participants to further deepen their understanding of Promoitalia’s treatment protocols, patient selection and clinical applications. The initiative reflects the company’s commitment to ensuring that innovation is supported by proper education and responsible practice.
By bringing Promoitalia to the Philippines, Pink Ventures is expanding access to internationally developed regenerative aesthetic technologies while helping elevate standards in physician education and patient care. As demand for minimally invasive aesthetic procedures continues to grow, the partnership positions both companies at the forefront of a new generation of aesthetic medicine—one that emphasizes scientific innovation, responsible clinical practice and natural-looking outcomes that prioritize skin health as much as beauty.
